pulmonary disease
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patients aged 18 to 75 years; 2. Patients undergoing VATS lobectomy and SLND; 4. ASA scores I-II grade; 5. Had essential complete materials such as clinical staging of lung cancer and medication; 6. Willing to participant after reading and signing an informed consent form.
Exclusion criteria
Exclusion criteria: 1. Time for smoking cessation <2 weeks; 2. Preoperative hydrothorax of patients was predominant; 3. Patients were pregnant or breastfeeding women; 4. Patients with preoperative severe mental illness; 5. Patients with preoperative gastrointestinal or blood system disease; 6. Patients underwent cardiac ischemia; 7. Patients received preoperative radiotherapy or neoadjuvant chemotherapy; 8. The investigator judges that the patient is not suitable for inclusion in the trial.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| the plasma level of leukocytes on 1-3 postoperative days;the plasma level of neutrophils on 1-3 postoperative days;Incidence of surgical complications; | — |
Secondary
| Measure | Time frame |
|---|---|
| Overall survival;3-year recurrence-free survival rate after operation; | — |
Countries
China